Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lindquist

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cornea|February 27, 2015
Mitomycin C-associated scleral stromalysis after pterygium surgeryT Peter Lindquist, W Barry Lee
Annual Review of Pharmacology and Toxicology|September 10, 2025
Incretin Signaling Neighborhoods and Adverse Drug ReactionsShane C Wright, Peter Lindquist, Mette M Rosenkilde, et al.
Retina (Philadelphia, Pa.)|February 11, 2014
Needle contamination in the setting of intravitreal injectionsDuncan A Friedman, T Peter Lindquist, John O Mason, et al.
Peptides|April 12, 2024
GIP-derived GIP receptor antagonists - a review of their role in GIP receptor pharmacologyMette Marie Rosenkilde, Peter Lindquist, Hüsün Sheyma Kizilkaya, et al.
Cornea|October 18, 2016
Rate of Rejection After Descemet Stripping Automated Endothelial Keratoplasty in Fuchs Dystrophy: Three-Year Follow-upLorena Sepsakos, Kevin Shah, T Peter Lindquist, et al.
Frontiers in Endocrinology|July 5, 2021
Mutational Landscape of the Proglucagon-Derived PeptidesPeter Lindquist, Jakob S Madsen, Hans Bräuner-Osborne, et al.
Frontiers in Endocrinology|July 18, 2022
The Location of Missense Variants in the Human GIP Gene Is Indicative for Natural SelectionPeter Lindquist, Lærke Smidt Gasbjerg, Jacek Mokrosinski, et al.
British Journal of Pharmacology|May 6, 2022
N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interactionMaria Buur Nordskov Gabe, Laerke Smidt Gasbjerg, Sarina Gadgaard, et al.
Chembiochem : a European Journal of Chemical Biology|May 3, 2024
Using LanM Enzymes to Modify Glucagon-Like Peptides 1 and 2 in E.coliCamilla K Larsen, Peter Lindquist, Mette Rosenkilde, et al.
Metabolism: Clinical and Experimental|January 10, 2026
Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK BiobankPeter A Gerlach, Sarina Gadgaard, Jakob S Madsen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cornea|February 27, 2015
Mitomycin C-associated scleral stromalysis after pterygium surgeryT Peter Lindquist, W Barry Lee
Annual Review of Pharmacology and Toxicology|September 10, 2025
Incretin Signaling Neighborhoods and Adverse Drug ReactionsShane C Wright, Peter Lindquist, Mette M Rosenkilde, et al.
Retina (Philadelphia, Pa.)|February 11, 2014
Needle contamination in the setting of intravitreal injectionsDuncan A Friedman, T Peter Lindquist, John O Mason, et al.
Peptides|April 12, 2024
GIP-derived GIP receptor antagonists - a review of their role in GIP receptor pharmacologyMette Marie Rosenkilde, Peter Lindquist, Hüsün Sheyma Kizilkaya, et al.
Cornea|October 18, 2016
Rate of Rejection After Descemet Stripping Automated Endothelial Keratoplasty in Fuchs Dystrophy: Three-Year Follow-upLorena Sepsakos, Kevin Shah, T Peter Lindquist, et al.
Frontiers in Endocrinology|July 5, 2021
Mutational Landscape of the Proglucagon-Derived PeptidesPeter Lindquist, Jakob S Madsen, Hans Bräuner-Osborne, et al.
Frontiers in Endocrinology|July 18, 2022
The Location of Missense Variants in the Human GIP Gene Is Indicative for Natural SelectionPeter Lindquist, Lærke Smidt Gasbjerg, Jacek Mokrosinski, et al.
British Journal of Pharmacology|May 6, 2022
N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interactionMaria Buur Nordskov Gabe, Laerke Smidt Gasbjerg, Sarina Gadgaard, et al.
Chembiochem : a European Journal of Chemical Biology|May 3, 2024
Using LanM Enzymes to Modify Glucagon-Like Peptides 1 and 2 in E.coliCamilla K Larsen, Peter Lindquist, Mette Rosenkilde, et al.
Metabolism: Clinical and Experimental|January 10, 2026
Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK BiobankPeter A Gerlach, Sarina Gadgaard, Jakob S Madsen, et al.
Pageof 2